Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results
Date:8/8/2011

with meeting the objectives of the PRIME study, including, but not limited to, delays or failures in enrollment, and the occurrence of adverse safety events, and other risks detailed from time to time in the Company's most recent Annual Report on Form 10-K and other documents subsequently filed with or furnished to the Securities and Exchange Commission. These forward-looking statements are based on current information that may change and you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and the Company undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.AVANIR PHARMACEUTICALS, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)Three Months Ended June 30,Nine Months Ended June 30,2011201020112010REVENUES FROM PRODUCT SALES   Gross product sales

$
2,187,124$
-$
2,692,090$
-   Less: discount and allowances

(254,889)-(297,841)-   Net product sales

1,932,235-2,394,249-   Cost of product sales

119,20880,000233,53580,000Product gross margin (deficit)

1,813,027(80,000)2,160,714(80,000)OTHER REVENUES   Revenues from royalties

547,900487,3503,340,8762,966,778Total gross margin

2,360,927407,3505,501,5902,886,778OPERATING EXPENSES   Research and development

3,258,9502,788,1329,622,12910,050,635   Selling, general and administrative

15,150,0533,733,15138,522,26410,222,333Total operating expenses

18,409,0036,521,28348,144,39320,272,968Loss from operations(16,048,076)(6,113,933)(42,642,803)(17,386,190)OTHER INCOME (EXPENSE)   Interest income

10,8482,66128,03110,822   Other, net

(28,332)389,689(28,295)390,366Net loss$ (16,065,560)$ (5,721,583)$ (42,64
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
2. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
4. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
5. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
6. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
7. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
8. AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results
9. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
10. Avanir Pharmaceuticals to Present at Three Conferences in March
11. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  A novel wearable injector slightly larger than an Oreo ... to self-inject prescription drugs in the large doses required to ... autoimmune deficiencies, and genetic disorders.  An emerging ... 2018, according to analysts.   Many of these drugs will require ...
(Date:1/14/2014)... (Nasdaq: LMNX ) today announced that it expects ... Monday, February 3, 2014. A press release announcing the results ... (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Management will ... financial results for the fourth quarter and twelve months ended ...
(Date:1/14/2014)... Calif. , Jan. 14, 2014 The Brandeis Medical Center, ... Angeles a premier and affordable laser tattoo removal experience ... Dr. Brandeis, focus is in providing high quality cosmetic services with ... patients. " Southern California has seen ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... -,Phytopharm plc (LSE: PYM) ("Phytopharm" or the ... reverses the,changes in the area of the ... be presented by Dr Jonathan Brotchie, an,internationally ... International Congress of Parkinson's Disease and Movement,Disorders' ...
... UVIDEM was well-tolerated with signs of durable,disease control ... 05, 2007 /PRNewswire-FirstCall/ -- IDM,Pharma, Inc. today presented ... vaccine clinical trial (DC-MEL-202). The,results showed that UVIDEM ... of immune response in patients with,progressive metastatic melanoma. ...
Cached Medicine Technology:Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 2Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 3Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 4Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 5IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 2IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 3IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 4IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 5
(Date:4/20/2014)... its potentially harmful effects in children, codeine continues to ... research from UCSF Benioff Children,s Hospital San Francisco. , ... , solutions include changing provider prescription behaviors to promote ... ibuprofen or hydrocodone. , "Despite strong evidence against the ... be prescribed to large numbers of them each year," ...
(Date:4/18/2014)... 2014) -- A group of scientists from the ... Sanders-Brown Center on Aging has found interesting new ... function in Parkinson,s disease (PD). , Published ... study, which assessed cognitive function in depressed and ... replacement therapy commonly used to treat motor symptoms ...
(Date:4/18/2014)... have made a discovery that turns 160 years of ... material long known to be essential for the fast ... is not as ubiquitous as thought, according to a ... Harvard Stem Cell Institute (HSCI) and the University,s Department ... Professor Jeff Lichtman, of Harvard,s Department of Molecular and ...
(Date:4/18/2014)... (Seattle, WA April 18, 2014) Benaroya Research ... to research how blocking a particular molecule in metastatic ... and the number of lung metastases. BRI scientists have ... protein can shrink tumors by 60 - 80 percent ... to the lung. The $1.8 million five-year grant comes ...
(Date:4/18/2014)... . A ... A team led by Ludwik Leibler from the Laboratoire ... Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits Paris ... principle of adhesion by aqueous solutions of nanoparticles can ... tissues. This easy-to-use gluing method has been tested on ...
Breaking Medicine News(10 mins):Health News:UCSF study finds codeine often prescribed to children, despite available alternatives 2Health News:Treating depression in PD patients: New research 2Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3
... Confirms Part D Seniors Also Enjoy Broad Choice of,Prescription ... Association (PCMA) issued the following statement on new budget,figures ... is lower over the,next ten years than was estimated ... without sacrificing beneficiaries,choice of prescription drugs. New budget documents ...
... Nursing Home Care to Face,Severe Resistance, JOPLIN, Mo., ... today reporting the Bush Administration plans to cut,U.S. seniors, ... to,be unveiled Monday, the Coalition to Protect Senior Care ... as it did last summer and fall when the,Coalition ...
... Mettler-Toledo,International Inc. (NYSE: MTD ) today announced ... fourth-quarter results on Thursday, February,7, 2008 at 5:00 p.m. ... call,visit http://www.mt.com/investors on the Company,s website. A ... 2008., METTLER TOLEDO is a leading global supplier ...
... off Sponsorship of Living ... Aid Retired NFL Players, PHOENIX, Jan. 31 Retired ... are more than twice as likely,as the general population to ... stroke and other cardiovascular (CV) diseases, according to,a recent study ...
... Ill., Jan. 31 Horace Mann,Educators Corporation (NYSE: ... Wednesday, February 6, 2008 after the market closes. The,earnings ... Relations section of the Company,s website at http://www.horacemann.com ... financial results on,Thursday, February 7, 2008 at 10:00 a.m. ...
... 31 National opinion leaders will,convene in Arlington, ... data,guidelines, practical applications, and strategies for the treatment ... make the,meeting highly interactive., The Summit will ... sponsored,by The Dannemiller Educational Foundation, and the content ...
Cached Medicine News:Health News:Coalition to Protect Senior Care Gearing Up to Fight Bush Administration Medicare Cuts 2Health News:NFL Linemen Predisposed to Cardiovascular Disease; Early Detection is Key to Getting and Staying Healthy 2Health News:NFL Linemen Predisposed to Cardiovascular Disease; Early Detection is Key to Getting and Staying Healthy 3Health News:Horace Mann Announces Fourth Quarter Earnings Release and Conference Call 2Health News:Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery 2Health News:Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: